Key Information for Investors of SelectQuote
Investors who have suffered losses exceeding $100,000 after investing in SelectQuote, Inc. (SLQT) are being reminded of an important class action lawsuit. This lawsuit is currently pending in the United States District Court for the Southern District of New York. A lead plaintiff application must be submitted by the specified deadline for individuals seeking participation in the legal process.
Understanding Your Rights as an Investor
If you purchased securities of SelectQuote and would like to understand your legal rights in relation to this lawsuit, Kahn Swick & Foti (KSF) is here to assist you. They encourage impacted investors to reach out without any obligations to explore their options and learn about their rights regarding recovery from potential economic losses.
Details of the Law Firm's Contact
For more information on how to proceed or ask questions regarding the lawsuit, investors may contact Lewis Kahn, the Managing Partner at KSF. You can reach out toll-free at 1-877-515-1850 or via email to discuss your situation, obligations, or next steps. KSF operates law offices in multiple locations and is equipped to handle securities litigation.
Background on the Securities Class Action
The lawsuit claims that SelectQuote and several of its executives failed to disclose material information relevant to investors, which constitutes a violation of federal securities laws. The allegations suggest serious misconduct that affected the financial interests of many shareholders.
Government Action Against SelectQuote
In a significant development, the U.S. Department of Justice filed a False Claims Act complaint against SelectQuote, alleging that between 2016 and 2021, the company received substantial kickbacks from health insurance companies. The claims indicate that the overpayments were made in exchange for directing Medicare beneficiaries toward specific plans, often prioritizing financial gain over the quality of service offered to clients.
Impact on SelectQuote’s Share Price
This news has dramatically impacted SelectQuote’s stock value. On the day the allegations were made public, the stock price plummeted by 19.2%, closing at $2.56 per share. Such fluctuations could have impacted many investors, furthering the case for the class action lawsuit.
The Case: Pahlkotter v. SelectQuote
Identified as Pahlkotter v. SelectQuote, Inc., et al., this case underscores the gravity of the situation surrounding SelectQuote’s legal challenges. Shareholders impacted by this situation need to be proactive in their legal responses.
About Kahn Swick & Foti, LLC
Established as one of the leading boutique securities litigation firms in the U.S., KSF provides representation for both institutional and retail investors navigating complex legal landscapes involving corporate fraud or mismanagement. Their experienced team, including former high-profile legal officials, has successfully handled securities cases nationwide.
Frequently Asked Questions
What is the lawsuit about?
The lawsuit involves allegations against SelectQuote and its executives for failing to disclose crucial information and engaging in unethical practices that harmed investors.
Who is eligible to file a lead plaintiff application?
Individuals who purchased SelectQuote securities and experienced significant financial losses are eligible to file.
What is the deadline to file?
The deadline to submit lead plaintiff applications is fast approaching; interested parties should submit their applications promptly.
How can Kahn Swick & Foti assist me?
KSF offers free consultations to assess your situation and advise you on how to proceed with your claim.
What implications does the DOJ's complaint have on investors?
The DOJ's complaint may indicate significant financial risks associated with SelectQuote, making it imperative for investors to take necessary legal action.
